Tag: medicare
R3 Vascular secures WCG IRB approval and CMS category B Medicare...
R3 Vascular today announced that it has received WCG Institutional Review Board (IRB) approval for the ELITE-BTK pivotal trial of its Magnitude drug-eluting next-generation...
CMS carotid stenting coverage expansion initiates concern over standard-of-care requirements and...
Dated 11 October 2023, the US Centers for Medicare & Medicaid Services (CMS) recently finalised its decision regarding National Coverage Determination (NCD) 20.7 for...
CMS confirms broadened Medicare coverage of carotid stenting in final decision...
The Centers for Medicare & Medicaid Services (CMS) has released its final decision regarding National Coverage Determination (NCD) 20.7 covering carotid artery stenting (CAS),...
VLF 2019: Real world data provide glimpse into peripheral drug-eluting devices...
Eric Secemsky (Boston, USA) takes Interventional News through the main highlights of his recently published analyses of a US Medicare claims dataset that examined...
New CMS reimbursement code “severely underpays” for drug-coated balloons
Drug-coated balloon (DCB) angioplasty devices have been categorised by the US Centers for Medicare and Medicaid Services (CMS) into the same billing code as...